Type / Class
Equity / Ordinary Shares, no par value and American Depositary Shares, each representing three hundred Ordinary Shares, no par value
Shares outstanding
3,543,587,624
Total 13F shares
539,567
Share change
+227,061
Total reported value
$2,823,081
Price per share
$5.22
Number of holders
9
Value change
+$1,191,800
Number of buys
5
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 75041J101?
CUSIP 75041J101 identifies RADX - Radiopharm Theranostics Ltd - Ordinary Shares, no par value and American Depositary Shares, each representing three hundred Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Radiopharm Theranostics Ltd - Ordinary Shares, no par value and American Depositary Shares, each representing three hundred Ordinary Shares, no par value (RADX) as of Q4 2025

As of 31 Dec 2025, Radiopharm Theranostics Ltd - Ordinary Shares, no par value and American Depositary Shares, each representing three hundred Ordinary Shares, no par value (RADX) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 539,567 shares. The largest 9 holders included HSBC HOLDINGS PLC, SILVERARC CAPITAL MANAGEMENT, LLC, Regal Partners Ltd, PNC Financial Services Group, Inc., Virtu Financial LLC, JANE STREET GROUP, LLC, UBS Group AG, Marex Group plc, and RHUMBLINE ADVISERS. This page lists 9 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.